Billionaire Stan Druckenmiller’s Small-Cap Stock Picks: Top 5 Stocks

3. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Stanley Druckenmiller’s Q2 2023 Investment: $10.4 million

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a biotechnology firm that develops drug discovery platforms and products. It scored a big win in August when the world’s leading artificial intelligence firm, NVIDIA Corporation, announced that it had entered into a partnership with Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) to train the latter’s AI models on NVIDIA’s products.

Stanley Druckenmiller’s Duquesne Family Office owned 1.3 million Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shares that were worth $10.4 million as of June 2023. Along with the firm, 15 of the 910 hedge fund portfolios studied by Insider Monkey had also held a stake in the firm. Out of these, the largest investor is Mubadala Investment’s MIC Capital Partners since it owns 8.4 million shares that are worth $63 million.

Follow Recursion Pharmaceuticals Inc.